Amplia Therapeutics Limited
INNMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $24,084 | $14,939 | $18,856 | $20,802 |
| - Cash | $10,863 | $3,385 | $9,257 | $14,609 |
| + Debt | $14 | $1,587 | $2,269 | $2,100 |
| Enterprise Value | $13,235 | $13,140 | $11,868 | $8,294 |
| Revenue | $3,784 | $4,453 | $1,189 | $1,983 |
| % Growth | -15% | 274.3% | -40% | – |
| Gross Profit | $3,573 | $4,011 | $1,116 | $1,980 |
| % Margin | 94.4% | 90.1% | 93.8% | 99.8% |
| EBITDA | -$6,782 | -$4,560 | -$7,264 | -$3,640 |
| % Margin | -179.2% | -102.4% | -610.7% | -183.6% |
| Net Income | -$6,572 | -$4,503 | -$6,242 | -$3,644 |
| % Margin | -173.7% | -101.1% | -524.8% | -183.7% |
| EPS Diluted | -0.021 | -0.023 | -0.032 | -0.025 |
| % Growth | 7.8% | 28% | -28.8% | – |
| Operating Cash Flow | -$6,886 | -$5,127 | -$5,290 | -$4,402 |
| Capital Expenditures | -$2 | -$2 | -$18 | -$14 |
| Free Cash Flow | -$6,888 | -$5,129 | -$5,307 | -$4,416 |